Sanofi-Aventis Prolongs Offer For Genzyme Until 1 April
From M&A Navigator (March 7, 2011)
French Sanofi-Aventis (EPA:SAN) said Monday it has decided to prolong its takeover offer for the outstanding stock of US biotechnology company Genzyme (NASDAQ:GENZ) until 1 April from 16 March.
Sanofi added it is now offering USD74 (EUR52.95) per share in cash, or a total of USD20.1bn for the US company, in addition to one contingent value right per share.
Sanofi further said it has secured above 1.1m shares, or 0.41% of Genzyme's outstanding stock on a fully-diluted base, as of 4 March.
Country: , USA
Target: Genzyme Corporation
Buyer: Sanofi-Aventis SA
Deal size in USD: 20.1bn
Type: Corporate acquisition
Comment: Offer has been extended.
((Comments on this story may be sent to firstname.lastname@example.org))
Posted: March 2011